Dilaudid and Tradjenta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dilaudid and Tradjenta. Common interactions include chronic kidney disease among females and cellulitis among males.

The phase IV clinical study analyzes what interactions people who take Dilaudid and Tradjenta have. It is created by eHealthMe based on reports of 21 people who take Dilaudid and Tradjenta from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

21 people who take Dilaudid and Tradjenta together, and have interactions are studied.


What is Dilaudid?

Dilaudid has active ingredients of hydromorphone hydrochloride. It is often used in pain. eHealthMe is studying from 87,684 Dilaudid users for its effectiveness, alternative drugs and more.

What is Tradjenta?

Tradjenta has active ingredients of linagliptin. It is often used in diabetes. eHealthMe is studying from 9,315 Tradjenta users for its effectiveness, alternative drugs and more.

Number of Dilaudid and Tradjenta reports submitted per year:

Dilaudid and Tradjenta drug interactions.

Common Dilaudid and Tradjenta drug interactions by gender *:

female:

  1. Chronic kidney disease
  2. Epistaxis
  3. Nausea
  4. Paranasal cyst
  5. Breast cancer
  6. Bronchitis
  7. Death
  8. Disability
  9. Ear infection
  10. Intraductal papillary mucinous neoplasm

male:

  1. Cellulitis
  2. Chronic kidney disease
  3. Scrotal swelling
  4. Testicular pain
  5. Abdominal discomfort
  6. Arthralgia
  7. Blood glucose increased
  8. Diarrhoea
  9. Disease progression
  10. Disturbance in attention

Common Dilaudid and Tradjenta drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Epistaxis
  2. Nausea
  3. Paranasal cyst
  4. Arthralgia
  5. Cellulitis
  6. Chronic kidney disease
  7. Death
  8. Disturbance in attention
  9. Gas gangrene
  10. Groin abscess

50-59:

  1. Cellulitis
  2. Chronic kidney disease
  3. Gas gangrene
  4. Groin abscess
  5. Groin pain
  6. Hyperparathyroidism secondary
  7. Necrotising fasciitis
  8. Nephrogenic anaemia
  9. Renal failure
  10. Scrotal cyst

60+:

  1. Death
  2. Breast cancer
  3. Pleural effusion
  4. Rash
  5. Renal cancer
  6. Renal failure acute
  7. Rhabdomyolysis
  8. Weight decreased
  9. Cellulitis
  10. Disease progression

Common conditions people have *:

  1. High Blood Pressure: 8 people, 38.10%
  2. High Blood Cholesterol: 5 people, 23.81%
  3. Stress And Anxiety: 4 people, 19.05%
  4. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 19.05%
  5. Cardiac Disorder: 3 people, 14.29%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 14.29%
  7. Type 2 Diabetes: 3 people, 14.29%
  8. Constipation: 2 people, 9.52%
  9. Depression: 2 people, 9.52%
  10. Gout (uric acid crystals building up in the body): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Dilaudid and Tradjenta?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Dilaudid and Tradjenta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Dilaudid interactions:

Browse all interactions between Dilaudid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Tradjenta interactions:

Browse all interactions between Tradjenta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydromorphone hydrochloride and linagliptin (the active ingredients of Dilaudid and Tradjenta, respectively), and Dilaudid and Tradjenta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Dilaudid and Tradjenta.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: